Government funds Ebola, Marburg vaccine

The federal government has granted researchers at Emory, the Georgia Institute of Technology and Texas Biomed a $5.4 million grant to further develop a vaccine against Ebola and Marburg hemorrhagic. The shot, which uses parts of the virus to elicit immunity, has already been tested in rats and will now be studied in nonhuman primates. Article

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.